查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594991

全球商店(OTC) 測試市場

Over The Counter (OTC) Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球商店(OTC) 檢測市場預計將達到 436 億美元

全球商店(OTC) 檢測市場預計 2023 年為 233 億美元，預計到 2030 年將達到 436 億美元，2023-2030 年分析期間複合年成長率為 9.3%。血糖監測測試是本報告分析的細分市場之一，預計複合年成長率為 8.2%，到分析期結束時將達到 117 億美元。在分析期間，妊娠和不孕症檢測行業的複合年成長率預計為 9.5%。

美國市場預計將成長63億美元，中國複合年成長率為8.8%

預計 2023 年美國商店(OTC) 檢測市場規模將達 63 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到68億美元，2023年至2030年的分析期間複合年成長率為8.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 7.8% 和 7.8%。在歐洲，德國的複合年成長率預計約為 6.6%。

全球非處方藥物 (OTC) 測試市場 - 主要趨勢和促進因素總結

為什麼商店測試對於可近的醫療保健至關重要？

非處方 (OTC) 檢測徹底改變了醫療保健，讓個人可以直接在家中方便地進行健康檢測。 OTC 測試可以監測各種健康指標，從血糖值和膽固醇水平到懷孕、不孕和感染疾病，無需醫生就診或處方箋。隨著醫療保健轉向更加以患者為中心和更容易獲得的護理，OTC 測試已成為尋求主動健康管理的個人的重要工具。方便的 OTC 檢測消除了與傳統實驗室檢測相關的障礙，例如時間、成本和可近性問題，使醫療保健更加全面。

非處方藥檢測對糖尿病等慢性病的管理影響特別大，持續監測對於有效照護至關重要。血糖值儀是最廣泛使用的非處方藥測試之一，它可以讓糖尿病患者追蹤他們的日常血糖值，幫助他們管理藥物和調整生活方式。同樣，家庭膽固醇測試可以讓有心血管疾病風險的人監測自己的健康狀況並做出明智的生活方式改變。隨著人口老化和慢性病的增加，OTC檢測為定期健康監測提供了實用的解決方案，並支持早期發現和介入。這種可近性不僅改善了個人的健康結果，而且還減輕了醫療機構的負擔，因為日常監測所需的資源更少。

此外，隨著越來越多的人尋求健康管理方法以應對健康意識的提高，非處方藥檢測也越來越受到關注。從針對計劃生育的夫婦的不孕不育測試，到了解家庭血統和傾向的基因檢測套組，OTC 測試正在滿足個性化預防性醫療保健的需求。隨著檢測技術的快速進步，可靠且易於使用的 OTC 檢測數量不斷增加，以滿足各種需求並讓個人了解自己的健康狀況。 OTC 測試透過向公眾提供診斷測試來彌合個人與及時醫療保健之間的差距，從而實現早期療育和主動健康管理。

技術進步如何加強 OTC 測試市場？

技術進步正在幫助 OTC 檢測市場不斷發展和壯大，使檢測更加準確、價格實惠且更易於使用。生化和分子生物學測試的創新顯著提高了 OTC 測試的靈敏度和特異性，為使用者提供了與實驗室測試相當的可靠結果。例如，側向層析和免疫測量技術的進步增強了對懷孕、感染疾病、藥物使用等的快速檢測。這些測試現在可以在幾分鐘內提供結果，為個人提供快速方便的健康見解。數位技術的整合，例如支援藍牙的血糖儀和智慧型手機應用程式，允許用戶追蹤、儲存和分析他們的健康資料，以幫助做出明智的決策並在需要時改善健康管理，幫助與護理提供者共用結果。

家庭基因檢測是另一個受益於技術進步的領域，使得分析唾液樣本中的 DNA 成為可能。曾經價格昂貴且只能在專業實驗室獲得的 DNA檢測套組現在可以透過 OTC 管道獲得，讓用戶能夠深入了解自己的血統、健康風險和遺傳傾向。這些檢測套組使用先進的基因組分析演算法和實驗室處理來解釋複雜的遺傳資料並以消費者友好的格式呈現。隨著人們對個人化健康資訊越來越感興趣，OTC 基因檢測提供了一種簡單的方法來了解遺傳健康風險，以指南生活方式選擇和預防性護理。個人化醫療保健的興起刺激了對這些測試的需求，並支持非處方藥測試技術的進一步創新。

遠端醫療和數位健康平台還透過創建連接家庭檢測和醫療保健提供者的生態系統來推動 OTC 檢測市場的成長。許多數位健康應用程式與 OTC 測試設備相容，允許用戶遠端諮詢醫療保健專業人員並根據測試結果獲得指導。 OTC 檢測和遠端醫療的這種整合為用戶提供了在家檢測和在線諮詢醫生的無縫體驗，所有這些都在短時間內完成。例如，透過 COVID-19 家庭檢測，您可以在舒適的家中接收檢測結果，減少您的接觸機會，並在需要時提供及時的醫療建議。隨著遠端醫療採用的擴大，家庭檢測和虛擬護理的協同效應將增強非處方藥檢測的相關性，從而創造一種優先考慮可及性和便利性的全面醫療保健體驗。

OTC 檢測對消費者和醫療保健提供者有哪些好處？

OTC 測試為消費者和醫療保健提供者提供了顯著的好處，並且是提高醫療保健可近性和效率的寶貴工具。 OTC 測試對消費者的主要好處是方便。由於您可以在家中進行測試，因此 OTC 測試消除了與傳統實驗室測試相關的日程安排、旅行和等待時間。這種便利性對於行動不便、居住在農村地區或日程繁忙而難以前往醫療機構的人們尤其有利。非處方測試（例如妊娠測試、血糖儀和快速抗原測試）可以為使用者提供即時結果，讓使用者安心無憂。透過減少實驗室訪問，OTC檢測使消費者能夠掌控自己的健康並隨時監測自己的健康狀況，並支持主動的健康管理。

對於患有慢性病的人來說，非處方藥檢測提供了持續健康監測的重要好處。定期居家檢測血糖值、膽固醇和血壓可以讓您預防併發症並及時進行醫療干預，從而更有效地管理您的健康狀況。這種連續監測功能可以方便地追蹤進展情況，無需頻繁就診，從而提高患者的依從性。非處方藥檢測還可以透過促進高膽固醇和血糖水平異常等疾病的早期檢測來改善健康結果。例如，家庭大腸癌篩檢測試可以及早發現並開始治療，從而顯著提高存活率。因此，非處方藥檢測在預防性醫療保健中發揮重要作用，幫助個人就其健康做出明智的決定。

對於醫療保健提供者而言，OTC 測試還具有減少對醫療設施的需求並允許提供者專注於危重病例的好處。透過讓患者獨立監測自己的健康狀況，OTC 檢測可以減少常規實驗室就診的次數，並為需要更強化治療的患者騰出資源。這對於滿足日益成長的醫療保健服務需求和最大限度地減少醫療保健系統的瓶頸特別有利。此外，從 OTC 測試收集的資料可以與醫療保健提供者共用，以便遠端監控慢性病患者。治療師可以使用這些資料來追蹤患者的進展、調整治療計劃並在出現問題時迅速介入。 OTC 測試支援醫療保健協作方法，透過促進有效的病患監測來改善結果並減少醫療保健基礎設施的壓力。

是什麼推動了 OTC 檢測市場的成長？

健康意識的提高、對可及的醫療保健解決方案的需求、檢測技術的進步以及慢性病患病率的增加等因素正在推動非處方藥檢測市場的成長。隨著健康意識不斷提高，越來越多的人正在尋找在家中監測健康狀況的工具，從而推動了對非處方藥檢測的需求。當今的消費者對自己的健康非常積極主動，OTC 測試提供了一種便捷的方法來檢查高血壓、膽固醇和血糖水平等疾病，而無需經常去看醫生。這種自我管理方法符合預防性醫療保健的成長趨勢，即個人定期監測自己的健康狀況，以便及早發現和解決潛在問題。

隨著世界各地的醫療保健系統面臨人口老化和管理有限資源的挑戰，對可訪問的醫療保健解決方案的需求也將極大地促進非處方藥檢測市場的成長。 OTC 檢測提供了一種經濟高效的解決方案，允許個人在家中接受定期檢測，減輕醫療機構的負擔，並讓更多的人能夠接受檢測。在醫療保健機會有限的農村和服務欠缺地區，非處方藥檢測透過提供基本的診斷功能而無需前往醫療機構，從而填補了空白。隨著醫療保健成本持續上升，非處方藥檢測提供了一種負擔得起的替代方案，支持廣泛獲得醫療保健，特別是在醫療保健基礎設施有限的地區。

測試準確性和易用性方面的技術進步也加速了 OTC 測試的採用。生物技術的創新提高了 OTC 測試的可靠性和特異性，使其高度準確且可與實驗室測試相媲美。例如，快速診斷測試的進步使得在家中檢測 COVID-19 和流感等感染疾病成為可能，從而為用戶提供及時的資訊以告知自我隔離和醫療護理決策。此外，遠端醫療的興起進一步將非處方藥測試整合到醫療保健中。遠距會診和數位健康平台使患者能夠根據家庭測試結果獲得醫療建議。 OTC 測試和遠端醫療的無縫整合對於尋求便捷且高效的醫療保健解決方案的患者尤其有吸引力。

最後，糖尿病、心血管疾病和高血壓等慢性病的盛行率不斷上升，推動了對可定期監測的非處方藥檢測產品的需求。由於慢性疾病需要頻繁的健康檢查，OTC 測試提供了一種方便有效的解決方案，使患者能夠持續監測自己的病情。管理這些慢性病的人通常使用血糖值監測儀、膽固醇測試和血壓監測儀，使他們能夠根據需要調整治療計劃。這種趨勢可能會持續下去，因為慢性病仍然是一個主要的公共衛生問題，而非處方藥檢測為患者提供了一種主動管理健康的方法。這些因素的結合，包括健康意識的提高、對可近醫療保健的需求、技術進步和慢性病的流行，導致非處方藥檢測市場顯著成長，使其成為現代醫療保健和預防醫學的基石。

部分

測試類型（血糖監測測試、懷孕/不孕症測試、傳染病檢查、凝血監測測試、尿液檢查、膽固醇測試、濫用藥物測試、其他測試類型）、技術（橫向流動化驗、免疫測量、試紙）

調查企業舉例（總合33家）

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP22445

Global Over The Counter (OTC) Testing Market to Reach US$43.6 Billion by 2030

The global market for Over The Counter (OTC) Testing estimated at US$23.3 Billion in the year 2023, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2023-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 Billion by the end of the analysis period. Growth in the Pregnancy & Fertility Tests segment is estimated at 9.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.3 Billion While China is Forecast to Grow at 8.8% CAGR

The Over The Counter (OTC) Testing market in the U.S. is estimated at US$6.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Over-the-Counter (OTC) Testing Market - Key Trends & Drivers Summarized

Why Is Over-the-Counter Testing Essential for Accessible Healthcare?

Over-the-counter (OTC) testing has revolutionized healthcare by providing individuals with direct access to health tests that can be conducted privately and conveniently at home. OTC tests enable users to monitor a range of health indicators, from blood glucose and cholesterol levels to pregnancy, fertility, and infectious diseases, without requiring a doctor’s visit or prescription. As healthcare shifts toward more patient-centered and accessible care, OTC testing has become an essential tool for individuals seeking to manage their health proactively. By allowing people to test at their convenience, OTC tests eliminate barriers associated with traditional lab-based testing, such as time, cost, and accessibility issues, making healthcare more inclusive.

OTC testing has been particularly impactful for managing chronic conditions like diabetes, where continuous monitoring is crucial for effective care. Blood glucose meters, one of the most widely used OTC tests, empower diabetic patients to track their sugar levels daily, aiding in medication management and lifestyle adjustments. Similarly, at-home cholesterol tests allow individuals at risk of cardiovascular disease to monitor their health and make informed lifestyle changes. With an aging population and increasing rates of chronic illnesses, OTC testing provides a practical solution for regular health monitoring, supporting early detection and intervention. This accessibility not only improves individual health outcomes but also reduces the burden on healthcare facilities, as fewer resources are required for routine monitoring.

Additionally, OTC testing has gained traction in response to rising health awareness, as more people seek ways to take control of their wellness. From fertility tests for couples planning a family to genetic testing kits for understanding ancestry and predispositions, OTC testing meets the demand for personalized, preventive healthcare. With rapid advances in testing technology, a growing range of reliable, user-friendly OTC tests is now available, catering to diverse needs and empowering individuals to stay informed about their health. By making diagnostic testing accessible to the general public, OTC testing bridges the gap between individuals and timely healthcare, enabling early interventions and proactive health management.

How Are Technological Advancements Enhancing the OTC Testing Market?

Technological advancements have been instrumental in the growth and evolution of the OTC testing market, making tests more accurate, affordable, and user-friendly. Innovations in biochemical and molecular testing have significantly improved the sensitivity and specificity of OTC tests, providing users with reliable results that are comparable to lab-based testing. For example, advancements in lateral flow and immunoassay technologies have enhanced rapid testing for conditions like pregnancy, infectious diseases, and drug use. These tests now produce results within minutes, offering individuals fast, convenient health insights. Digital technology integration, such as Bluetooth-enabled blood glucose meters and smartphone apps, allows users to track, store, and analyze their health data, helping them make informed decisions and share results with healthcare providers as needed.

At-home genetic testing is another area that has benefited from technological advancements, making it possible to analyze DNA from a simple saliva sample. DNA testing kits, which were once expensive and only available through specialized labs, are now accessible through OTC channels and provide users with insights into their ancestry, health risks, and genetic predispositions. These kits use advanced genomic analysis algorithms and lab processing to interpret complex genetic data, presenting it in an accessible format for consumers. As people become more interested in personalized health information, OTC genetic testing offers an easy way to understand genetic health risks, which can guide lifestyle choices and preventive care. The rise of personalized healthcare has fueled demand for these tests, supporting further innovation in OTC testing technology.

Telemedicine and digital health platforms have also driven growth in the OTC testing market by creating an ecosystem that connects at-home testing with healthcare providers. Digital health apps, many of which are compatible with OTC testing devices, allow users to consult healthcare professionals remotely and receive guidance based on their test results. This integration of OTC testing with telemedicine provides a seamless experience, where users can test at home and consult a doctor online, all within a short timeframe. For example, COVID-19 home tests allow individuals to receive test results without leaving their home, reducing exposure and facilitating timely medical advice if needed. As telemedicine adoption expands, the synergy between at-home testing and virtual care strengthens the relevance of OTC tests, creating a holistic healthcare experience that prioritizes accessibility and convenience.

What Are the Benefits of OTC Testing for Consumers and Healthcare Providers?

OTC testing provides substantial benefits for both consumers and healthcare providers, making it a valuable tool in enhancing healthcare accessibility and efficiency. For consumers, the main advantage of OTC testing is convenience. By enabling people to test at home, OTC testing eliminates the need for scheduling, travel, and waiting times associated with traditional lab tests. This convenience is especially beneficial for individuals with mobility issues, those living in rural areas, or people with busy schedules who find it challenging to visit a healthcare facility. OTC tests, such as pregnancy tests, blood glucose meters, and rapid antigen tests, offer users immediate results and peace of mind. By reducing the dependency on lab visits, OTC testing empowers consumers to take control of their health and monitor their well-being at any time, supporting proactive health management.

For individuals with chronic conditions, OTC testing offers the critical benefit of continuous health monitoring. Regular at-home testing for blood glucose, cholesterol, or blood pressure enables individuals to manage their conditions more effectively, preventing complications and allowing for timely medical interventions. This continuous monitoring capability improves patient compliance, as users can conveniently track their progress without frequent clinic visits. OTC tests also enhance health outcomes by promoting early detection of conditions like high cholesterol or abnormal glucose levels, allowing individuals to make lifestyle changes or seek medical advice before conditions worsen. For example, at-home colon cancer screening tests allow for early detection, significantly improving survival rates when treatment begins early. OTC testing thus plays a crucial role in preventive care, supporting individuals in making informed decisions about their health.

Healthcare providers also benefit from OTC testing, as it helps alleviate the demand on healthcare facilities and enables providers to focus on critical cases. By empowering patients to monitor their health independently, OTC testing reduces the number of routine lab visits, freeing up resources for patients who require more intensive care. This is particularly beneficial in managing the rising demand for healthcare services and minimizing bottlenecks in the healthcare system. Additionally, data collected from OTC testing can be shared with healthcare providers, allowing for remote monitoring of patients with chronic conditions. Providers can use this data to track patient progress, make adjustments to treatment plans, and intervene promptly if issues arise. By facilitating efficient patient monitoring, OTC testing supports a collaborative approach to healthcare that enhances outcomes and reduces the burden on healthcare infrastructure.

What Is Fueling the Growth in the OTC Testing Market?

The growth in the OTC testing market is driven by factors such as rising health awareness, the need for accessible healthcare solutions, advancements in testing technology, and the increasing prevalence of chronic conditions. As health awareness continues to rise, more people are seeking tools that allow them to monitor their health from home, leading to a greater demand for OTC tests. Consumers today are more proactive in managing their health, and OTC testing offers a convenient way to check for conditions like high blood pressure, cholesterol, and glucose levels without the need for frequent doctor visits. This self-management approach aligns with the growing trend of preventive healthcare, where individuals monitor their health regularly to detect and address potential issues early.

The need for accessible healthcare solutions has also contributed significantly to the growth of the OTC testing market, as healthcare systems worldwide face challenges in meeting the demands of an aging population and managing limited resources. OTC testing provides a cost-effective solution by enabling individuals to take routine tests at home, reducing the burden on healthcare facilities and making testing accessible to a wider population. In rural or underserved areas where healthcare access is limited, OTC testing bridges the gap by providing essential diagnostic capabilities without requiring travel to a medical facility. As healthcare costs continue to rise, OTC testing offers an affordable alternative that supports broader access to healthcare, especially in regions with limited medical infrastructure.

Technological advancements in testing accuracy and ease of use have also accelerated the adoption of OTC testing. Innovations in biotechnology have improved the reliability and specificity of OTC tests, making them highly accurate and comparable to lab-based tests. For instance, advancements in rapid diagnostic tests have made it possible to detect infectious diseases like COVID-19 and influenza at home, providing users with timely information that can guide decisions on self-isolation and medical care. Additionally, the rise of telehealth has further integrated OTC testing into healthcare, as remote consultations and digital health platforms allow patients to receive medical advice based on their at-home test results. This seamless integration of OTC testing and telemedicine is especially appealing to patients seeking accessible and efficient healthcare solutions.

Finally, the increasing prevalence of chronic conditions, such as diabetes, cardiovascular disease, and high blood pressure, has fueled demand for OTC testing products that allow for regular monitoring. As chronic diseases require frequent health checks, OTC testing offers a convenient, effective solution for patients to monitor their condition consistently. Blood glucose monitors, cholesterol tests, and blood pressure cuffs are commonly used by individuals managing these chronic conditions, enabling them to adjust their treatment plans as needed. This trend is likely to continue as chronic conditions remain a significant public health issue, with OTC testing providing patients with the tools to manage their health proactively. Together, these factors—rising health awareness, the need for accessible healthcare, technological advancements, and the prevalence of chronic conditions—are driving substantial growth in the OTC testing market, making it a cornerstone of modern healthcare and preventive medicine.

SCOPE OF STUDY:

The report analyzes the Over The Counter (OTC) Testing market in terms of US$ Million by the following Technology; Test Type, and Geographic Regions/Countries:

Segments:

Test Type (Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests, Other Test Types); Technology (Lateral Flow Assays, Immunoassays, Dipsticks)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Home-Based Health Monitoring Drives OTC Testing Market
    • Increasing Awareness About Preventive Healthcare Sets the Stage for OTC Testing Adoption
    • Rising Adoption of Self-Testing Kits for Chronic Disease Management
    • Increasing Use of OTC Testing in Monitoring Infectious Diseases Propels Demand
    • Demand for Rapid and Accurate Results Spurs OTC Testing Solutions
    • OTC Testing as a Key Solution for Reducing Healthcare Costs
    • Use in Detecting Lifestyle Disorders Expands OTC Testing Adoption
    • Rising Demand for Genetic Testing Kits Sets the Stage for Market Growth
    • Increasing Use of OTC Testing in Monitoring Diabetes and Heart Conditions
    • Increasing Focus on Female Health Solutions Expands OTC Testing Opportunities
    • OTC Testing for Allergies and Food Intolerances Generates Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Over The Counter (OTC) Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • JAPAN
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • CHINA
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • EUROPE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • FRANCE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • GERMANY
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030

IV. COMPETITION